A Facile Nanodelivery Platform Based on Functionalized Hyperbranched Poly(ether-ester) for Individualized Antitumor Drugs: Pingyangmycin as a Model
Figure 7
(a) HN6 cell viability following treatment with various concentrations of HPEE-pingyangmycin nanocarriers or pingyangmycin alone for 24 h. (b) HN6 cell viability following treatment with various concentrations of HPEE-pingyangmycin nanocarriers or pingyangmycin alone for 48 h.
